Schisandrin B protects rat cortical neurons against Aβ1-42- induced neurotoxicity

Pharmazie

Volumn 64, Issue 7, 2009, Pages 450-454

  Wang, Bin ^a   Wang, Xue Mei ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CASPASE 3; CASPASE 9; CYTOCHROME C; GLUTATHIONE; GLUTATHIONE DISULFIDE; PROTEIN BAX; PROTEIN BCL 2; SCHIZANDRIN B; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); CYCLOOCTANE DERIVATIVE; LIGNAN; NERVE PROTEIN; NEUROPROTECTIVE AGENT; PEPTIDE FRAGMENT; POLYCYCLIC HYDROCARBON;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BRAIN CELL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT; UPREGULATION; ANIMAL; BRAIN CORTEX; CELL SURVIVAL; CYTOLOGY; DRUG ANTAGONISM; METABOLISM; NERVE CELL; WISTAR RAT;

AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 9; CELL SURVIVAL; CEREBRAL CORTEX; CYCLOOCTANES; CYTOCHROMES C; GLUTATHIONE; LIGNANS; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; POLYCYCLIC COMPOUNDS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR;

EID: 70349251736     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2009.9552     Document Type: Article

References (23)

1. Antonsson B, Martinou JC (2000): The Bcl-2 protein family. Exp Cell Res 256: 50-57.
2. Boise LH, Gonzalez Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB (1993) Bcl-x, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608.
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
4. Chen N, Chiu PY, Ko KM (2008) Schisandrin B enhances cerebral mitochondrial antioxidant status and structural integrity, and protects against cerebral ischemia/reperfusion injury in rats. Biol Pharm Bull 31: 1387-1391.
5. 2+-induced mitochondrial permeability transition and mitochondrial membrane potential in H9c2 cardiomyocytes. Life Sci 82: 1092-1101.
6. Hardy JA, Higgins GA (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256: 184-185.
7. Jiang Q, Wang J, Wu X, Jiang Y (2007) Alterations of NR2B and PSD-95 expression after early-life epileptiform discharges in developing neurons. Int J Dev Neurosci 25: 165-170.
8. Kirsch DG, Doseff A, Chau BN, Lim DS, de Souza-Pinto NC, Hansford R, Kastan MB, Lazebnik YA, Hardwick JM (1999) Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J Biol Chem 274: 21155-21161.
9. Kluck RM, Bossy Wetzel E, Green DR, Newmeyer DD (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136.
10. Marin N, Romero B, Bosch-Morell F, Llansola M, Felipo V, Roma J, Romero FJ (2000) Beta-amyloid-induced activation of caspase-3 in primary cultures of rat neurons. Mech Aging Dev 119: 63-67.
11. Masumura M, Hata R, Nishimura I, Uetsuki T, Sawada T, Yoshikawa K (2000) Caspase-3 activation and inflammatory responses in rat hippocampus inoculated with a recombinant adenovirus expressing the Alzheimer amyloid precursor protein. Mol Brain Res 80: 219-227.
12. Meister A, Anderson ME (1983) Glutathione. Annu Rev Biochem 52: 711-760.
13. Morais Cardoso S, Swerdlow RH, Oliveira CR (2002) Induction of cytochrome c-mediated apoptosis by amyloid beta 25-35 requires functional mitochondria. Brain Res 931: 117-125.
14. Paradis E, Douillard H, Koutroumanis M, Goodyer C, LeBlanc A (1996) Amyloid β peptide of Alzheimer's disease down regulates Bcl-2 and up regulates Bax expression in human neurons. J Neurosci 16: 7533-7539.
15. Recknagel RO, Glende EA (1989) The carbon tetrachloride hepatotoxicity model: Free radicals and calcium homeostasis, Hand book of free radicals and antioxidants in biomedicine, CRC Press, Boca Raton.
16. Reed DJ (1990) Glutathione: toxicological implications. Annu Rev Pharmacol Toxicol 30: 603-631.
17. Schubert D, Behl C, Lesley R, Brack A, Dargusch R, Sagara Y, Kimura H (1995) Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci (U.S.A.) 92: 1989-1993.
18. Schulz JB, Lindenau J, Seyfried J, Dichgans J (2000) Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267: 4904-4911.
19. Selkoe DJ (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399: A23-A31.
20. Smith CV, Jones DP, Guenthner TM, Lash LH, Lauterburg BH (1996) Compartmentation of glutathione: implications for the study of toxicity and disease. Toxicol Appl Pharmacol 140: 1-12.
21. Tamagno E, Parola M, Guglielmotto M, Santoro G, Bardini P, Marra L, Tabaton M, Danni O (2003) Multiple signaling events in amyloid-β induced, oxidative stress-dependent neuronal apoptosis. Free Radic Biol Med 35: 45-58.
22. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB (1997) Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91: 627-637.
23. Wolf BB, Green DR (1999) Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 274: 20049-20052.